Matches in Wikidata for { <http://www.wikidata.org/entity/Q58604500> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q58604500 description "articolo scientifico (pubblicato il 2019)" @default.
- Q58604500 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q58604500 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q58604500 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58604500 description "scientific article published on 01 February 2019" @default.
- Q58604500 description "wetenschappelijk artikel" @default.
- Q58604500 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q58604500 name "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 name "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 name "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 type Item @default.
- Q58604500 label "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 label "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 label "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 prefLabel "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 prefLabel "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 prefLabel "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 P1433 Q58604500-96AB1917-63D9-486D-8F53-12594D34339A @default.
- Q58604500 P1476 Q58604500-EA10D49D-01FC-44B5-AA47-61E41BA93A9E @default.
- Q58604500 P2093 Q58604500-7AACF016-0891-417B-B302-EEB0350F06D8 @default.
- Q58604500 P2093 Q58604500-9416FD6F-E12A-4506-A619-5EA764A298DB @default.
- Q58604500 P2093 Q58604500-CC807583-414F-4530-9DF2-600D4B36AA04 @default.
- Q58604500 P2093 Q58604500-DABBF81C-1716-4986-8648-EEC5C196A9F0 @default.
- Q58604500 P2093 Q58604500-F95AAFF7-075D-49F0-9705-CD5DD5F1BA3C @default.
- Q58604500 P304 Q58604500-117B2170-0866-4E20-98A9-7FB45C92D768 @default.
- Q58604500 P31 Q58604500-2B684658-7366-490D-8ED3-E7CFBE4891D2 @default.
- Q58604500 P356 Q58604500-2E7E55FE-0B1D-4C89-9A0B-68B565E7F35A @default.
- Q58604500 P407 Q58604500-53F63A3C-31D6-494A-86D4-DF0EDE8DDD7A @default.
- Q58604500 P433 Q58604500-D0F7F818-FC9F-49A6-B1D9-2FE4BB62C7CE @default.
- Q58604500 P478 Q58604500-B5168D82-F328-441D-8F5B-E053491CC525 @default.
- Q58604500 P577 Q58604500-602F4EAC-248C-4A72-922E-2E2AFD5EA1B3 @default.
- Q58604500 P698 Q58604500-0A9E703D-D039-4C67-B537-A6069C0E72ED @default.
- Q58604500 P921 Q58604500-9C625C52-46F9-4CF8-8104-7754799D73F5 @default.
- Q58604500 P356 S41395-018-0368-1 @default.
- Q58604500 P698 30333541 @default.
- Q58604500 P1433 Q7713501 @default.
- Q58604500 P1476 "Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease" @default.
- Q58604500 P2093 "Cesar Rodriguez" @default.
- Q58604500 P2093 "Danning Ma" @default.
- Q58604500 P2093 "Helen Wu" @default.
- Q58604500 P2093 "Jeremie Aviado" @default.
- Q58604500 P2093 "Wendy Wong" @default.
- Q58604500 P304 "352-354" @default.
- Q58604500 P31 Q13442814 @default.
- Q58604500 P356 "10.1038/S41395-018-0368-1" @default.
- Q58604500 P407 Q1860 @default.
- Q58604500 P433 "2" @default.
- Q58604500 P478 "114" @default.
- Q58604500 P577 "2019-02-01T00:00:00Z" @default.
- Q58604500 P698 "30333541" @default.
- Q58604500 P921 Q917447 @default.